Envista - NVST Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Envista in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" NVST shares.
View NVST analyst ratings or view top-rated stocks.

5 Wall Street analysts have issued 1-year target prices for Envista's stock. Their NVST share price forecasts range from $43.00 to $50.00. On average, they expect the company's share price to reach $46.00 in the next year. This suggests a possible upside of 20.3% from the stock's current price.
View analysts price targets for NVST or view top-rated stocks among Wall Street analysts.

Envista's stock was trading at $33.67 at the beginning of 2023. Since then, NVST stock has increased by 13.6% and is now trading at $38.24.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our NVST earnings forecast.

Envista Holdings Co. (NYSE:NVST) released its quarterly earnings results on Wednesday, February, 8th. The company reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.49 by $0.03. The business earned $660.80 million during the quarter, compared to the consensus estimate of $658.40 million. Envista had a net margin of 9.46% and a trailing twelve-month return on equity of 8.52%. The business's revenue for the quarter was up 1.4% on a year-over-year basis. During the same period last year, the company earned $0.46 earnings per share.

ETFs with the largest weight of Envista (NYSE:NVST) stock in their portfolio include Thrivent Small-Mid Cap ESG ETF (TSME), First Trust Health Care AlphaDEX Fund (FXH), Schwab Ariel ESG ETF (SAEF), SPDR S&P Health Care Equipment ETF (XHE), Invesco S&P MidCap Quality ETF (XMHQ), Fidelity Small-Mid Cap Opportunities ETF (FSMO), First Trust Horizon Managed Volatility Small/Mid ETF (HSMV) and iShares U.S. Medical Devices ETF (IHI).

9 employees have rated Envista Chief Executive Officer Amir Aghdaei on Glassdoor.com. Amir Aghdaei has an approval rating of 21% among the company's employees. This puts Amir Aghdaei in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

(NVST) raised $603 million in an initial public offering on Wednesday, September 18th 2019. The company issued 26,800,000 shares at $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley served as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

Envista trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVST."

Envista's stock is owned by a variety of retail and institutional investors. Top institutional investors include Boston Partners (4.30%), Artisan Partners Limited Partnership (3.72%), Dimensional Fund Advisors LP (3.42%), Ariel Investments LLC (3.09%), Alliancebernstein L.P. (2.58%) and Montrusco Bolton Investments Inc. (2.57%). Insiders that own company stock include Amir Aghdaei, Curt W Bludworth, Curt W Bludworth, Howard H Yu, Jeffrey Kappler, Mark E Nance, Mark E Nance and Mischa Reis.
View institutional ownership trends.

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NVST stock can currently be purchased for approximately $38.24.

Envista (NYSE:NVST) has a market capitalization of $6.24 billion and generates $2.57 billion in revenue each year. The company earns $243.10 million in net income (profit) each year or $1.37 on an earnings per share basis.

The company employs 12,700 workers across the globe.

Envista's mailing address is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. The official website for the company is www.envistaco.com. The company can be reached via phone at 714-817-7000, via email at ir@envistaco.com, or via fax at 714-817-5450.